ALR Technologies Enters Latin America with Clinical Trials in Chile
14 Octubre 2014 - 7:00AM
Access Wire
Richmond, VA / ACCESSWIRE / October 14, 2014 / ALR
Technologies Inc. (OTC: ALRT) has signed an agreement to
launch a clinical outcomes study in Chile as a potential solution
to the growing number of diabetic patients in Latin America. ALRT's
Health-e-Connect is the only off-the-shelf, FDA-cleared
system to allow diabetic patients to remotely connect with
physicians through a secure website, where Diabetes Care
Facilitators (DCFs) regularly monitor the patients' data looking
for readings outside of specified parameters.The upcoming trial
follows ALRT's first large-scale commercial deployment of the
Health-e-Connect system in the United States through the Kansas
City Metropolitan Physicians Association in September. The Latin
America trial will treat 100 diabetic patients in Santiago, Chile,
with a successful trial expected to help establish a presence for
ALRT in the large Latin American market.
"Our system is relatively inexpensive, and with Latin America
traditionally not spending quite as much in health care per patient
as the US, our system is ideal for there Latin American market and
this trial will be the way to prove it," says ALRT President Bill
Smith on the "Good Life Revolution" with Jesse Dylan this week,
powered by Megacast.
The trial will take two groups of 100 patients each at the
Hospital Clinico Metropolitano de la Florida, one of Chile's
largest hospitals. The first group will be put on ALRT's Remote
Monitoring System with DCFs intervening when adverse trends are
identified in a patient's blood glucose levels. The second group of
100 patients will record their blood glucose levels through
standard traditional practices by manually logging their own data.
ALRT will compare the results at the end of the 6-month trial
period. The trial's primary goal will be to decrease patient A1c
levels, the measure of average levels of blood glucose over the
prior three months regarded as the gold standard in diabetes
management. A reduction in A1c reduces the risk of potentially
deadly complications of diabetes.A successful trial would reduce
average patient A1c levels below 8 percent, the benchmark point for
diabetes control.
Watch President Bill Smith on the "Good Life Revolution"
Discussing Why ALRT Chose Chile For The Clinical Trial
"Chile has a lot of patients with uncontrolled blood glucose, so
if we can prove that our system can get large numbers of patients
below 8%, that will get a lot of attention with public health
authorities not just in Chile, but in Latin America,"adds ALRT
President Bill Smith.
The results of the test will be available on ALRT's website with
an eye towards publishing the data in an academic journal in the
United States.
In the United States, the federal Medicare program is
considering a proposal to reimburse physicians for this type of
remote monitoring.In its annual physician payment update for 2015,
the Centers for Medicare and Medicaid Services (CMS) proposed to
pay physicians for "Chronic Care Management" which would pave the
way for remote monitoring technologies like ALRT's Health-e-Connect
system to treat Medicare patients with chronic diseases.CMS will
make this potentially watershed decision on November 1 and, if
decided favorably, reimbursement would flow on January 1, 2015.
By 2030, 50 million diabetes patients are expected to be
diagnosed in North America, with an additional 40 million diagnosed
in Latin America. Enrolling a mere 1% of these patients into the
ALRT program would put ALRT significantly in the black and reflect
a return on investment for the company and its investors.
ALRT continues to trade on the public market (OTC: ALRT) and its
entire portfolio of Stock Information and SEC Filings are available
on its website www.alrt.com.
About MEGACAST
MEGACAST is a 21st Century Digital Branding and Advertising
Agency with exclusive expertise in Branding & Design, Content
Creation, Viral Marketing and Distribution. In addition to boasting
the first Integrated Performance Marketing Strategy all under one
roof, the company offers comprehensive Live Streaming capabilities;
complete PPV functionality; Digital Marketing, Advertising and
Distribution solutions; Web and Mobile Application development, and
a combined audience reach of more than 100 million. Businesses
spend less, achieve more and save substantial time in the process
with the MEGACAST suite of services.
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote
monitoring and care facilitation for patients with chronic
conditions. ALRT has developed the FDA-cleared and HIPAA compliant
Health-e-Connect System that collects data from blood glucose
meters and uploads to a secure website. Trained Facilitators use
the System to effect efficiency of care among patients, clinicians
and caregivers to improve outcomes and assist health plans to
optimize their quality goals. Currently, the Company is focused on
diabetes and will expand its services to cover other chronic
conditions anchored on verifiable data. More information about ALR
Technologies, Inc. can be found at www.alrt.com.
ALR Technologies is active in providing articles, videos and
information on diabetes via social media. ALR Technologies can be
found on Facebook
at: https://www.facebook.com/ALRTechnologies and on Twitter
at: https://twitter.com/ALRTechnologies.
ALRT Electronic Press Kit: http://www.glntv.tv/alrt
Forward Looking Statements
This release contains certain "forward-looking statements"
relating to ALR Technologies' business, and these statements
reflect the current views of ALR Technologies with respect to
future events and are subject to certain risks, uncertainties and
assumptions. When used, the words "estimate", "expect",
"anticipate", "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors
that could cause the actual results, performance or achievements of
ALR Technologies and its products to be materially different from
any future results, performances or achievements that may be
expressed or implied by such forward-looking statements. Further
management discussions of risks and uncertainties can be found in
the company's quarterly filings with the Securities
Exchange.
SOURCE: ALR Technologies Inc.
ALR Technologies (QB) (USOTC:ALRT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ALR Technologies (QB) (USOTC:ALRT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024